Back to search results

Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome

Abroad (travel likely)Recruiting

Conditions

Diarrhea-predominant Irritable Bowel Syndrome · Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Medical Center Ho Chi Minh City, Ho Chi Minh City, District 5, Vietnam

    Contact: Study coordinator (Assoc. Professor. Thong Duy Vo, M.D. Ph.D.) · thong.vd@umc.edu.vn · +84 932039888
    Contact: Study coordinator (Qui Huu Nguyen, M.D.) · qui.nh@umc.edu.vn · +84 975560142
    Contact: Principal Investigator (Assoc. Professor. Thong Duy Vo, M.D. Ph.D.)
    Huong Tu Lam, M.D. (Sub-investigator)
    Qui Huu Nguyen, M.D. (Sub-investigator)
    Thuy Thanh Thi Trinh, M.D. (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)